Foreign Collusion, Naked Shorting (Counterfeiting) & Money Laundering — All Illicit Wealth
How the COVID-19 Bailout Gave Wall Street a No-Lose Casino
While ordinary Americans face record unemployment and loss, the COVID-19 bailout has saved the very rich
Matt Taibbi
Rolling Stone, 13 May 2020
This financial economy is a fantasy casino, where the winnings are real but free chips cover the losses. For a rarefied segment of society, failure is being written out of the capitalist bargain.
Continue reading “Article: How the COVID-19 Bailout Gave Wall Street a No-Lose Casino”
In ‘Cum-Ex’ Crackdown, EBA Tells Supervisors to Look at AML Compliance
KYC360, 13 May 2020
EU banking supervisors must investigate Cum-Ex transactions and other dividend arbitrage schemes as part of their reviews of anti-money laundering (AML) compliance programs, the bloc’s banking authority said Tuesday.
The European Banking Authority (EBA) said in a report that recent surveys of the bloc’s AML and prudential supervisors indicate that member-states “do not share the same understanding of dividend arbitrage trading schemes and the extent to which financial institutions’ handling of the proceeds from these schemes constitutes money laundering.” The handling of funds linked to such schemes “is likely to amount to money laundering, irrespective of where the tax crime took place,” the EBA said.
CymaBay Therapeutics (CBAY) at Yahoo Finance
Now learn this company is owned almost 90% by funds you can only own 100% of a stock , NOW add in retail holders i bet that is 100% easy its a $2-$4 stock then add in NON reporting funds around the WORLD lets say 20% more
The short in this name is at least 120% more then float so if float is 62M so my guess the total naked short in this name is easy about 80M shares so the NEW trading float adding in all the fakes is now 80+62M or 140M shares
Welcome to FRAUD St how does that help shareholders or the company? IT DOESN’T
Continue reading “Tip: CymaBay Therapeutics Being Naked Short Sold”
Tesla Inc.: Anatomy Of A Trade
Dan Stringer
SeekingAlpha, 13 May 2020
The premeditated and coordinated market manipulation in $TSLA is working today.
ACB did the reverse how is it doing the last 2 days? STRAIGHT down just more money to steal instead of a penny stock they sell a $7 stock the CAR WASH
here are prices and volume last 2 days HIGH was $8.21 now $6.80 on that wonderful news
Yahoo Pricing on Aurora Cannabis
THANK YOU NYSE kicking them off because of Price now the animals will just steal again
Another great study is ticker IBIO https://www.ibioinc.com/
Investigation needed!
A current company that would make for a great real time story and investigation is Plug Power ticker PLUG.
For over 20 years from its IPO in 1999 stock price has declined from an IPO price of over $1,000. a share to low of .80 cents with today stuck at $4.31. A new CEO started April 2008 stock price was $32.10 many suspect he’s part of the Naked Short Selling crime spree… making MILLIONS of Dollars in compensation from a non-profitable company. This is a new technology company in the hydrogen fuel cell business. https: www.plugpower.com
After a Reverse Split, Can Aurora Cannabis Also Reverse the Downward Trend?
Aurora Cannabis (ACB) is one of the major players in the Canadian pot industry, but along with many other Canadian cannabis stocks, the hype has failed to deliver profits and meet investors’ expectations. As a result, the share price has collapsed by over 90% since early May last year.
Comment: Naked short selling killed this company. Why would a reverse have anything do with business? its means nothing But the stories seem to say the reverse can change the downtrend? HOW?
CymaBay Doubles After-Hours On Positive NASH Trial Update
first 1/2 hr of trading 22 MILLION shares traded everyone who is long wanted to see on this great news HURRY RUN away someone is selling a boat load of naked shorts for sure
Now the funny part the stock is down from a high of $13 to a low of $1.21 and the stories will be written today that stock is soaring or some other word saying stock has gone up enough. That’s how they get people to sell stock has doubled RUN away.
Continue reading “Tip: Today’s Naked Short Selling Victim CymaBay”
David Solomon is Chairman and Chief Executive Officer and a member of the Board of Directors of The Goldman Sachs Group, Inc. Previously, he was President and Chief Operating Officer of Goldman Sachs. Prior to that, he served as Co-Head of the Investment Banking Division from 2006 to 2016. Before that, Mr. Solomon was Global Head of the Financing Group, which includes all capital markets and derivative products for the firm’s corporate clients. He joined Goldman Sachs as a Partner in 1999.
John E. Waldron is President and Chief Operating Officer of The Goldman Sachs Group, Inc. He is a member of the Goldman Sachs Management Committee and Chair of the Firmwide Client and Business Standards Committee and Firmwide Reputational Risk Committee. Previously, Mr. Waldron was Co-Head of the Investment Banking Division (IBD) from 2014 to 2018. Prior to that, he was Global Head of Investment Banking Services (IBS)/Client Coverage for IBD and had oversight of the IBS Leadership Group, a group he founded in 2010. Earlier in his career, he was Global Co-Head of the Financial Sponsors Group from 2007 to 2009, Co-Head of Leveraged Finance from 2005 to 2007 and Co-Head of the Media and Entertainment Group in IBD from 2002 to 2005. Mr. Waldron joined Goldman Sachs in 2000 and was named Managing Director in 2001 and Partner in 2002.
Stephen M. Scherr is Chief Financial Officer of Goldman Sachs. He serves on the Management Committee, Firmwide Risk Committee, Firmwide Asset Liability Committee and Firmwide Investment Policy Committee. Scherr joined Goldman Sachs in 1993 as an Associate in the Financial Institutions Group. In 1996, he transferred to Emerging Markets/Capital Markets in the Fixed Income, Currency and Commodities Division. In 1998, Scherr moved to the Communications, Media and Entertainment Group. He served as Chief Operating Officer for the Investment Banking Division from 2005 to 2007 and was Head of the Americas Financing Group before serving as Global Head of the Financing Group from 2008 to 2014.
John F. W. Rogers serves as Executive Vice President, the firm’s Chief of Staff and Secretary to the Board of Directors of The Goldman Sachs Group, Inc.. He oversees Executive Administration and is responsible for the firm’s corporate affairs functions, including public, investor and government relations, as well as corporate engagement. He is also Chairman of the Goldman Sachs Foundation. Mr. Rogers joined Goldman Sachs in 1994. He was named Managing Director in 1997 and Partner in 2000. Previously, Mr. Rogers served as Under Secretary of State for Management at the US Department of State from 1991 to 1993. From 1988 to 1991, he was Executive Vice President of the Oliver Carr Company. Earlier, Mr. Rogers served as Assistant Secretary of the Treasury from 1985 to 1987 and as an Assistant to the President of the United States at the White House from 1981 to 1985.
Laurence Stein is the Chief Administrative Officer of The Goldman Sachs Group, Inc. He is a member of the Management Committee, Client and Business Standards Committee and Enterprise Risk Committee. Prior to his current role, Stein was Global Head of the Operations Division. From 2009 to 2015, he served as Chief Operating Officer of the Securities Division. From 2005 to 2009, Mr. Stein was Chief Financial Officer for the Investment Banking Division and the Federation, and before that, served as Chief Financial Officer of the Securities Division. He joined Goldman Sachs in 1996 in the Finance Division, and was named Managing Director in 2003 and Partner in 2006. Prior to joining the firm, Mr. Stein worked in the Financial Services Group at Ernst & Young in New York and Deloitte & Touche in South Africa.
THE DOLLAR HAS NO INTRINSIC VALUE : DO YOUR ASSETS?
